Axitinib Pharmacokinetics in Chinese Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions
Healthy Volunteers
Interventions
DRUG

AG-013736 (axitinib)

Three single oral-doses of AG-013736 (5-mg, 7-mg and 10-mg) will be successively administered (each separated by a washout period of at least 7 days) to healthy Chinese volunteers in the fed state.

Trial Locations (1)

100730

Pfizer Investigational Site, Beijng

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY